Paul Martin

发表

Patient Donor Gender Patient female Donor female Donor multiparous Patient and donor negative Acute myeloid leukemia Non-Hodgkin ' s lymphoma Acute lymphoid leukemia Hodgkin ' s disease CML Multiple myeloma

R. Storb, F. Appelbaum, T. Gooley, 2002 .

Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report

P. Lachenbruch, D. Miklos, E. Holler, 2006 .

The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review

K. Sullivan, A. Sung, N. Chao, 2016, Digestive Diseases and Sciences.

A pilot study of low‐dose cyclosporin for graft‐versus‐host prophylaxis in marrow transplantation

M. Pepe, K. Sullivan, R. Storb, 1992, British journal of haematology.

Interleukin‐23 receptor signaling by interleukin‐39 potentiates T cell pathogenicity in acute graft‐versus‐host disease

E. Bartee, M. Sofi, Steven D. Schutt, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Loss of B7-H1 Expression by Recipient Parenchymal Cells Leads to Expansion of Infiltrating Donor CD8+ T Cells and Persistence of Graft-Versus-Host Disease

Lieping Chen, Z. Meng, Wei He, 2012, The Journal of Immunology.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

James Ferrara, Peter A Lachenbruch, Daniel Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors

K. Sullivan, R. Storb, F. Appelbaum, 1988 .

Graft-versus-Host Disease : The Pesky Fly in the Ointment

H. Heslop, R. Soiffer, Richard J. Jones, 2007 .

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia

K. Sullivan, R. Storb, F. Appelbaum, 2003 .

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.

B. Storer, P. Westervelt, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Coronary artery occlusion secondary to graft versus host disease after bone marrow transplant in a 21-year-old

M. J. Campbell, Sihong Huang, Paul Martin, 2018, Cardiology in the Young.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Li Li, Sandra A Mitchell, Kristin Baird, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia

K. Sullivan, R. Storb, F. Appelbaum, 1989 .

Marrow Transplantation for Severe Aplastic Anemia

K. Sullivan, R. Storb, F. Appelbaum, 2020 .